http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-27574-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| filingDate | 2002-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87067df09383b771b773c397aa6f5064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45590828fce09c7cdec31e2339d1a132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed172706ac3d841ba73dc3fa4bfa61ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ab77634fa1c5c10678b83b5aa3f78f8 |
| publicationDate | 2003-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UY-27574-A1 |
| titleOfInvention | USE OF BENZOTIAZOLES UREAS |
| abstract | Use of compounds of the general formula for the treatment of diseases related to the adenosine A2 receptor system, including Alzheimer's, Parkinson's, Huntington's disease, neuroprotection, schizophrenia, anxiety, pain, respiratory deficiencies, depression, drug addiction, eg amphetamines, cocaine, opioids, ethanol, nicotine, cannabinoids, or asthma, allergic reactions, hypoxia, ischemia, seizures and medication abuse. They can also be useful as sedatives, muscle relaxants, antisychotics, antiepiletic agents, anticonvulsants, cardioprotective agents in disorders such as coronary artery disease and heart failure. |
| priorityDate | 2001-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.